CDK5 and hepatocellular carcinoma: However, because flavonoids can inhibit Cdk5 [20] and Cdk5/p35 signaling (which is not regulated by cell cycling) is active in hepatoma [25], we tested whether inhibition of Cdk5 by flavonoids is responsible for the flavonoids-mediated activation of PXR.